UC Professor Advocated for New Law on HIV Positive Organ Donation

CINCINNATI—University of Cincinnati (UC) research professor of medicine Rita Alloway, PharmD, has spent years working to update a 20-year ban on HIV positive organ donation—and her efforts, along with those of dozens of others—are being rewarded today with the signing of the HOPE Act into law by President Barack Obama.

The HOPE (HIV Organ Policy Equity) Act ends the federal ban on research into organ donations from HIV-positive donors to HIV-positive recipients, and paves the way for eventual transplantation of those organs to help HIV-positive recipients in need of a new liver, kidney, or potentially other organs. 

Alloway, who calls today’s signing "very rewarding,” advocated for the act in her role as board and public policy committee member of the American Society of Transplantation, an international organization of transplant professionals. Alloway also directs UC’s transplant clinical research program.

She says that allowing research into positive-to-positive donations—and creating safeguards and standards for such donations—will help to expand the pool of available organs for the more than 100,000 patients currently on the waiting list in the United States.

"The current rate limiting factor for patients awaiting transplant is the availability of a donor organ,” she says. "Medically-sound efforts to increase the donor pool, such as the HOPE Act, will dramatically decrease wait times for HIV positive recipients, and thus provide more organs within the organ pool.”

A study published in the American Journal of Transplantation estimated that allowing organ transplants from HIV-positive donors to HIV-positive recipients could increase the organ pool by 500 to 600 donors a year, saving hundreds of lives.

From 2003 to 2009, UC participated in a multicenter collaborative studying transplantation in HIV infected patients. The study, led locally by professors of medicine Prabir Roy-Chaudhury, MD, PhD, and Kenneth Sherman, MD, has led to many publications advancing this area of patient care. 

"The need for increased donor has always been the Achilles heel for transplantation,” says Alloway. "Specifically for the HIV transplant population, the advent of effective HIV treatments, and research proving HIV positive transplant patients have similar outcomes post-transplant, has allowed transplantation to be a viable option for these patients.”

Additionally, the HOPE Act requires the national organ procurement and transplantation network (OPTN) to develop standards ensuring positive-to-positive transplantation does not impact the safety of the organ transplantation network. It also amends federal criminal law on HIV transmission to clarify that positive-to-positive donations are not barred.

The bipartisan legislation, sponsored by U.S. Sens. Barbara Boxer (D-Calif.) and Tom Coburn (R-Okla.) and 13 other senators, passed the U.S. Senate in June and was approved by the House of Representatives Tuesday, Nov. 12. The House bill was sponsored by Reps. Lois Capps (D-Calif.) and Andy Harris (R-Md.).

Tags

Related Stories

1

Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December

December 12, 2025

This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.

2

Ohio nurses weigh in on proposed federal loan rule

December 12, 2025

Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.

3

New combination treatment improves multiple myeloma outcomes

December 11, 2025

The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.